p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors

Related Experiment Video

Updated: Jun 1, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Sriram Venneti1, Paul Le, Daniel Martinez

  • 1Division of Neuropathology, Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA.

Journal of Neuropathology and Experimental Neurology
|June 14, 2011
PubMed

Insights

Malignant rhabdoid tumors (MRTs) show deregulated cell cycle pathways, specifically involving p16INK4A and p14ARF. This deregulation offers insights into tumor development and potential therapeutic targets for aggressive MRTs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant rhabdoid tumors (MRTs) are aggressive neoplasms linked to SMARCB1 gene mutations.
  • Loss of SMARCB1 is hypothesized to disrupt tumor suppressor pathways, including p16INK4A.
  • Understanding cell cycle deregulation is crucial for MRT pathogenesis and treatment.

Purpose of the Study:

  • To investigate the status of p16INK4A/E2F1/RB and p14ARF/MDM2/p53 pathways in human MRTs.
  • To determine if these pathways are deregulated in atypical teratoid/rhabdoid tumors (AT/RT) and non-CNS MRTs.
  • To correlate pathway alterations with TP53 mutational status and nucleophosmin expression.

Main Methods:

  • Immunohistochemistry was performed on tissue microarrays from 25 AT/RT and 11 non-CNS MRT cases.
  • Evaluation included markers for p16INK4A, E2F1, RB, p14ARF, MDM2, p53, and nucleophosmin.
  • TP53 mutational analysis was conducted on a subset of tumor samples.

Main Results:

  • p16INK4A expression was low or absent, with variable expression of its downstream targets.
  • p14ARF was frequently expressed, correlating positively with p53 and inversely with MDM2 in AT/RT.
  • TP53 mutations were infrequent, suggesting p53 expression is primarily driven by p14ARF; nucleophosmin was frequently positive and colocalized with p53.

Conclusions:

  • Human MRTs exhibit deregulation of both the p16INK4A and p14ARF cell cycle pathways.
  • These findings provide critical insights into the molecular pathogenesis of MRTs.
  • The identified pathway alterations may inform the development of novel therapeutic strategies for MRTs.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...